MUHC Second Annual Women's Heart Health Symposium 2020

Thursday, November 19, 2020

Virtual Format  (ZOOM link will be sent to all registrants)

 

8:45 - 8:55

ZOOM waiting room

8:55 - 9:00

Welcome - Louise Pilote, MD MPh PhD

PART 1:

Addressing cardiovascular risk factors in women to prevent cardiovascular disease: a one-fits-all approach?

Moderator - Tamara Jennifer Ibrahim, MDCM, CCFP, MPhil, Assistant Professor, Family Medicine

9:00 - 9:30

Louise Pilote, MD MPh PhD
Professor, Department of Medicine

Overview of sex and gender differences in the epidemiology and importance of cardiovascular risk factors

PDF icon Louise Pilote PPT

Learning Objectives

  1. Summarize sex differences in the prevalence of cardiovascular disease risk factors
  2. Outline sex differences in the magnitude of effects of cardiovascular disease risk factors

9:30 - 10:00

Stella Daskalopoulou, MD MSc DIC PhD
Associate Professor, Department of Medicine

A personalized sex-specific approach to management of hypertension

Learning Objectives

  1. Illustrate blood pressure trajectories throughout a woman’s lifespan
  2. Identify women specific risk factors for high blood pressure
  3. Explain women specific blood pressure management therapies
  4. Describe women specific end organ damage from hypertension

10:00 - 10:30

Tricia Peters, MD PhD MPhil
Assistant Professor, Department of Medicine

Diabetes and cardiovascular disease in women

PDF icon Tricia Peters PPT

Learning Objectives

  1. Explain women specific risk factors for diabetes
  2. Review evidence supporting glycemic targets in women throughout the lifespan
  3. Discuss the use of anti-hyperglycemic agents to attain glycemic control among women

10:30 - 11:00

Natalie Dayan, MD MSc
Assistant Professor, Department of Medicine

Preconception cardiovascular disease risk factor management to optimize pregnancy outcomes and overall health

PDF icon Natalie Dayan PPT

Learning Objectives

  1. Appreciate the burden of cardiovascular disease risk factors among reproductive-aged women
  2. Recognize the impact of uncontrolled cardiovascular disease risk factors on maternal and perinatal morbidity
  3. Outline strategies for cardiovascular disease risk factor optimization

11:00 - 11:15

Break

PART 2:

Tailored Cardiovascular Risk Reduction Approaches: Where are we now and where are we going?

Moderator - Natalie Dayan, MD MSc

11:15 - 11:45

Wendy Wray, RN MScN BScN
Director, Women's Healthy Heart Initiative (WHHI)
and

Tamara Jennifer Ibrahim, MDCM CCFP MPhil
Assistant Professor, Family Medicine

Panel discussion - Shared care for primary prevention of cardiovascular disease in the community: lessons learned in a nurse-led women’s heart disease primary prevention clinic

Moderator: Louise Pilote, MD MPh PhD

Learning Objectives

  1. Summarize the relationship and challenges in cardiovascular risk management and successful patient engagement in healthy lifestyle behaviors-pearls and pitfalls
  2. Identify the principles and benefits of a patient centered care model of care in engaging patients in healthy lifestyle behaviors
  3. Discuss achievable methods in implementing a more patient centered approach in a clinical setting

11:45 - 12:15

Steven Grover, MD MPA FRCPC
Professor, Department of Medicine

Preventing cardio-metabolic disease among women- Maximizing the impact of healthy lifestyle habits including regular physical activity and weight management

PDF icon Steven Grover PPT

Learning Objectives

  1. Explain the importance of physical activity and body weight as risk factors among women
  2. Outline the prevalence of these risk factors over the lifetime
  3. Discuss the challenges and solutions surrounding weight loss and increasing physical activity

     

    12:15 - 12:45

    George Thanassoulis, MD MSc FRCPC
    Associate Professor, Department of Medicine

    New Approaches to Prevent Heart Disease in Women

    PDF icon George Thanassoulis PPT

    Learning Objectives

    1. Demonstrate the relationship between early risk factors and cardiovascular disease in women
    2. Identify strategies for early primary prevention in women
    3. Role of advanced lipoprotein testing (apoB, Lp(a)) in determining cardiovascular risk

    12:45 - 12:55

    Andréane Tardif, RD MSc 
    Specialist, Lived Experience Engagement and Support

    Heart & Stroke updates and opportunities in Research on Women's Heart and Brain Health

    PDF icon Andréane Tardif PPT

    12:55 - 1:00 Closing Remarks - Wendy Wray, RN MScN BScN


     

    Back to top